It is a healthcare private limited company based in Mumbai, Maharashtra, India, established in 2021.
2021 | Mumbai, Maharashtra, India | ActiveRraynex Pharmaceuticals Private Limited, a active private limited company, was established on 09 November 2021 in Mumbai, Maharashtra, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds CIN: U24299MH2021PTC371078. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹14.72 Cr.
It upholds a compliant status. Its leadership includes Raina Dilip Desai (Director), Minal Dilip Desai (Additional Director), Nishit Gupta (Director). It holds ₹5.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 701, 7Th Floor, Leela Business Park Opp Leela Hotel, Ak Road, Andheri(East), Mumbai, Maharashtra, 400059.
U24299MH2021PTC371078
371078
09 November 2021
₹15.00 Cr
₹14.72 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Rraynex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raina Dilip Desai | Director | 09 Nov 2021 | Current |
| Minal Dilip Desai | Additional Director | 11 Aug 2023 | Current |
| Nishit Gupta | Director | 09 Nov 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rraynex Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 28865.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 78.7%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Rraynex Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2024 | Axis Bank Limited | ₹5.00 Cr | Open |
Explore comprehensive loan charge details -
Rraynex Pharmaceuticals has a workforce of 0 employees as of Jun 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rraynex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rraynex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Axis Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101010006 was registered on 30 Oct 2024. was completed.
Progress on Rraynex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Rraynex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity Minal Dilip Desai was appointed as a Additional Director was appointed as a Additional Director on 11 Aug 2023 & has been associated with this company since 2 years 3 months . was completed.
Raina Dilip Desai was appointed as a Director was appointed as a Director on 09 Nov 2021 & has been associated with this company since 4 years 20 days . was recorded as a recent event.
Nishit Gupta was appointed as a Director was appointed as a Director on 09 Nov 2021 & has been associated with this company since 4 years 20 days . was recorded as a recent event.
The CIN of Rraynex Pharmaceuticals Private Limited is U24299MH2021PTC371078.
Rraynex Pharmaceuticals Private Limited is headquartered at 701, 7Th Floor, Leela Business Park Opp Leela Hotel, Ak Road, Andheri(East), Mumbai, Maharashtra, 400059.
Rraynex Pharmaceuticals Private Limited was incorporated on 09 November 2021.
The current directors of Rraynex Pharmaceuticals Private Limited are
The primary industry of Rraynex Pharmaceuticals Private Limited is Healthcare.
Rraynex Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rraynex Pharmaceuticals Private Limited is ₹15.00 Cr, and the paid-up capital is ₹14.72 Cr.
The compliance status of Rraynex Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX